Profiling resistance-related mutations in the protease region of the pol gene: single genome sequencing of HIV in plasma and peripheral blood mononuclear cells.
Genotypic resistance is currently assessed through direct sequencing, which cannot detect resistant strains below 20%. We compared the genotypic resistance profile of virions and proviruses using population-based analysis and single genome sequencing of the protease region of the pol gene in samples collected from five individuals in whom indinavir monotherapy resulted in treatment failure. Single genome sequencing showed that not all strains present the same resistance mutations, which can be dispersed across different HIV genomes. The resistance profile found in plasma was very similar to that found in peripheral blood mononuclear cells (PBMCs), confirming the utility of assessing proviral DNA as for a means of determining antiretroviral resistance.
Guimarães
Ana Paula
AP
Federal University of São Paulo, São Paulo, Brazil 04020-041.
Sa-Filho
Dercy Jose
DJ
Sucupira
Maria Cecilia
MC
Janini
Luiz Mario
LM
Diaz
Ricardo Sobhie
RS
D000595:Amino Acid Sequence; D024882:Drug Resistance, Viral / Q000235:genetics; D006678:HIV / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D016333:HIV Protease / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology* / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000821:virology*; D008969:Molecular Sequence Data; D009154:Mutation; D010949:Plasma / Q000821:virology*; D011533:Proviruses / Q000235:genetics; D016415:Sequence Alignment; D017211:Treatment Failure; D014771:Virion / Q000235:genetics
D017320:HIV Protease Inhibitors; D019469:Indinavir; D016333:HIV Protease